Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Stopped early · Phase 1
Conditions studied: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy consisting of liposomal doxorubicin and etoposide in treating patients who have recurrent or persistent ovarian, fallopian tube, or peritoneal cancer.
Key facts
- Study ID
- NCT00003380
- Run by
- Gynecologic Oncology Group
- Starts
- 1998-05-01
- Last updated by the study team
- 2013-06-10
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
Where it is running
- CCOP - Greater Phoenix — Phoenix, Arizona, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Women's Cancer Center — Palo Alto, California, United States
- University of Colorado Cancer Center — Denver, Colorado, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Emory University Hospital - Atlanta — Atlanta, Georgia, United States
- CCOP - Atlanta Regional — Atlanta, Georgia, United States
- MBCCOP - Hawaii — Honolulu, Hawaii, United States
- Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- CCOP - Evanston — Evanston, Illinois, United States
- CCOP - Central Illinois — Springfield, Illinois, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
- Johns Hopkins Oncology Center — Baltimore, Maryland, United States
- Medicine Branch — Bethesda, Maryland, United States
- Radiation Oncology Branch — Bethesda, Maryland, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- CCOP - Ann Arbor Regional — Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.